SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.40 Cr | ₹1.40 Cr | - | ₹1.40 Cr | - |
What is the latest Contingent Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.40 Cr |
| Mar2024 | ₹1.40 Cr |
| Mar2023 | - |
| Mar2022 | ₹1.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.40 Cr | 0.00 | |
| Mar2024 | ₹1.40 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹1.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,721.4 Cr | -1% | -4.7% | 68.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -1% |
-4.7% |
68.3% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses